As a drug with a high risk of hypoglycaemia, 144 patients were taking SU, and two were taking glinide; the other two patients were taking dipeptidyl peptidase 4 inhibitors (DPP4i) alone. The gene discussed is DPP4; the disease is Hypoglycemia.